Contact
searchSearch
HMP Global

Pharmacy Learning Network

PharmLaw

PharmLaw
Tennessee Nurse Practitioner Found Guilty in Controlled-Substance Prescribing Case
06/02/2026
Grace Taylor, MS, MA
A Tennessee nurse practitioner has been convicted of illegally distributing Schedule II opioids, according to the Department of Justice.
A Tennessee nurse practitioner has been convicted of illegally distributing Schedule II opioids, according to the Department of Justice.
A Tennessee nurse practitioner...
06/02/2026
Pharmacy Learning Network
PharmLaw
CVS Challenges Tennessee Law Restricting PBM Ownership of Pharmacies
05/27/2026
Hannah Musick
CVS Health has sued the Tennessee state legislature over a new law barring pharmacy benefit managers (PBMs) from owning pharmacies, setting up a potentially significant legal battle over state authority to regulate vertically integrated...
CVS Health has sued the Tennessee state legislature over a new law barring pharmacy benefit managers (PBMs) from owning pharmacies, setting up a potentially significant legal battle over state authority to regulate vertically integrated...
CVS Health has sued the...
05/27/2026
Pharmacy Learning Network
PharmLaw
North Carolina Reaches $11 Million EpiPen Settlement Over Pricing Practices
05/06/2026
Grace Taylor, MS, MA
North Carolina secured an $11 million settlement with Mylan over alleged EpiPen pricing and rebate practices that impacted Medicaid and state health plan costs.
North Carolina secured an $11 million settlement with Mylan over alleged EpiPen pricing and rebate practices that impacted Medicaid and state health plan costs.
North Carolina secured an $11...
05/06/2026
Pharmacy Learning Network
PharmLaw
Purdue Pharma Sentenced in Federal Opioid Case, Finalizing Fraud and Kickback Conspiracy Resolution
04/29/2026
Grace Taylor, MS, MA
Purdue Pharma’s federal sentencing finalizes a landmark opioid case involving fraud and kickback conspiracies, with lasting compliance implications for the pharmaceutical supply chain.
Purdue Pharma’s federal sentencing finalizes a landmark opioid case involving fraud and kickback conspiracies, with lasting compliance implications for the pharmaceutical supply chain.
Purdue Pharma’s federal...
04/29/2026
Pharmacy Learning Network
PharmLaw
Drug Lobby Challenges Washington State 340B Pharmacy Law
04/27/2026
Grace Taylor, MS, MA
A leading pharmaceutical trade group has filed a federal lawsuit challenging Washington state’s new 340B law, arguing it unlawfully interferes with manufacturer control over drug distribution and pricing requirements.
A leading pharmaceutical trade group has filed a federal lawsuit challenging Washington state’s new 340B law, arguing it unlawfully interferes with manufacturer control over drug distribution and pricing requirements.
A leading pharmaceutical trade...
04/27/2026
Pharmacy Learning Network

FDA Recalls

News
MG217 Treatment Cream and Skin Protectant Recalled Due to Staphylococcus Aureus Contamination
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network
News
Pred Mild Eye Drops Recalled Due to Failed Stability Specifications
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for Pred Mild, prednisolone acetate ophthalmic suspension, due to failed stability specifications, affecting 2736 bottles.
The US Food and Drug Administration (FDA) has issued a Class III recall for Pred Mild, prednisolone acetate ophthalmic suspension, due to failed stability specifications, affecting 2736 bottles.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network
News
Nicotine Transdermal System Patches Recalled Due to Failed Impurities/Degradation Specifications
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for nicotine transdermal system patches, 14mg, due to the product’s failure to meet impurities/degradation specifications, affecting 59 808 pouches.
The US Food and Drug Administration (FDA) has issued a Class III recall for nicotine transdermal system patches, 14mg, due to the product’s failure to meet impurities/degradation specifications, affecting 59 808 pouches.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network
News
Busulfan Injections Recalled Due to Failed Impurities/Degradation Specifications
05/28/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for busulfan injections, 60mg per 10mL (6mg per mL) due to the presence of particulate matter, affecting 9528 vials.
The US Food and Drug Administration (FDA) has issued a Class III recall for busulfan injections, 60mg per 10mL (6mg per mL) due to the presence of particulate matter, affecting 9528 vials.
The US Food and Drug...
05/28/2026
Pharmacy Learning Network
News
Liraglutide Injections Recalled Due to the Presence of Particulate Matter
05/28/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for liraglutide injections, 18mg/3mL (6mg/mL) due to the presence of particulate matter, affecting 217 621 pen injectors.
The US Food and Drug Administration (FDA) has issued a Class II recall for liraglutide injections, 18mg/3mL (6mg/mL) due to the presence of particulate matter, affecting 217 621 pen injectors.
The US Food and Drug...
05/28/2026
Pharmacy Learning Network

In the News

News
MG217 Treatment Cream and Skin Protectant Recalled Due to Staphylococcus Aureus Contamination
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network
News
Pred Mild Eye Drops Recalled Due to Failed Stability Specifications
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for Pred Mild, prednisolone acetate ophthalmic suspension, due to failed stability specifications, affecting 2736 bottles.
The US Food and Drug Administration (FDA) has issued a Class III recall for Pred Mild, prednisolone acetate ophthalmic suspension, due to failed stability specifications, affecting 2736 bottles.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network
News
Nicotine Transdermal System Patches Recalled Due to Failed Impurities/Degradation Specifications
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for nicotine transdermal system patches, 14mg, due to the product’s failure to meet impurities/degradation specifications, affecting 59 808 pouches.
The US Food and Drug Administration (FDA) has issued a Class III recall for nicotine transdermal system patches, 14mg, due to the product’s failure to meet impurities/degradation specifications, affecting 59 808 pouches.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network
PharmLaw
Tennessee Nurse Practitioner Found Guilty in Controlled-Substance Prescribing Case
06/02/2026
Grace Taylor, MS, MA
A Tennessee nurse practitioner has been convicted of illegally distributing Schedule II opioids, according to the Department of Justice.
A Tennessee nurse practitioner has been convicted of illegally distributing Schedule II opioids, according to the Department of Justice.
A Tennessee nurse practitioner...
06/02/2026
Pharmacy Learning Network
News
Busulfan Injections Recalled Due to Failed Impurities/Degradation Specifications
05/28/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for busulfan injections, 60mg per 10mL (6mg per mL) due to the presence of particulate matter, affecting 9528 vials.
The US Food and Drug Administration (FDA) has issued a Class III recall for busulfan injections, 60mg per 10mL (6mg per mL) due to the presence of particulate matter, affecting 9528 vials.
The US Food and Drug...
05/28/2026
Pharmacy Learning Network

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use